文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

模拟重症监护环境中呼吸支持设备相关病毒扩散的定量评估

Quantitative Assessment of Viral Dispersion Associated with Respiratory Support Devices in a Simulated Critical Care Environment.
PubMed 文献 · Am J Respir Crit Care Med · 2021-01-01
一句话结论模拟ICU研究显示,无创通气、高流量鼻氧和鼻导管产生的噬菌体气溶胶浓度显著高于有创通气,头盔通气和有创通气最低。

该研究在模拟ICU房间中使用呼出雾化噬菌体的呼吸患者模拟器,比较有创通气(带气囊的气管插管连接呼吸机)、带PEEP阀的头盔通气、无创双水平正压通气、非重复呼吸面罩、高流量鼻氧和鼻导管等呼吸支持方式的病毒扩散。结果显示有创通气和带PEEP阀的头盔通气空气噬菌体浓度最低,高流量鼻氧和鼻导管最高;在插管位置,高流量鼻氧、鼻导管、非重复呼吸面罩和双水平正压通气相关噬菌体浓度均显著高于有创通气(P<0.05),头盔通气与有创通气差异无统计学意义。作者认为这提示不同呼吸支持设备扩散病毒的风险可能不同,并强调医务人员在照护可传播呼吸道病毒感染患者时采取适当感染防控措施和个人防护装备的重要性。

要点

  • 在插管位置,高流量鼻氧相关噬菌体浓度为2.66×10^4 PFU/L空气采样,显著高于有创通气(P<0.05)。
  • 鼻导管相关噬菌体浓度为1.60×10^4 PFU/L空气采样,显著高于有创通气(P<0.05)。
  • 非重复呼吸面罩相关噬菌体浓度为7.87×10^2 PFU/L空气采样,显著高于有创通气(P<0.05)。
  • 双水平正压通气相关噬菌体浓度为1.91×10^2 PFU/L空气采样,显著高于有创通气(P<0.05)。
  • 带PEEP阀的头盔通气相关噬菌体浓度为4.29×10^-1 PFU/L空气采样,与有创通气差异无统计学意义。

适用人群与场景

  • 模拟ICU房间中的呼吸患者模拟器,从下呼吸道呼出雾化噬菌体,比较不同呼吸支持方式的病毒扩散。

处置流程与药物剂量

  • 有创通气:通过带气囊的气管插管连接机械通气。
  • 头盔通气:使用带PEEP阀的头盔通气。
  • 无创双水平正压通气。
  • 非重复呼吸面罩。
  • 高流量鼻氧(HFNO)。
  • 鼻导管。

研究设计与关键结果

  • 研究类型为模拟ICU环境实验,使用呼吸患者模拟器定量比较不同呼吸支持方式的病毒扩散。
  • 有创通气和带PEEP阀的头盔通气与最低的空气噬菌体浓度相关,高流量鼻氧和鼻导管与最高浓度相关。
  • 在插管位置,高流量鼻氧(2.66×10^4 PFU/L空气采样)、鼻导管(1.60×10^4 PFU/L空气采样)、非重复呼吸面罩(7.87×10^2 PFU/L空气采样)和双水平正压通气(1.91×10^2 PFU/L空气采样)相关噬菌体浓度均显著高于有创通气(P<0.05)。
  • 带PEEP阀的头盔通气(4.29×10^-1 PFU/L空气采样)与有创通气相关噬菌体浓度差异无统计学意义。

证据类型、等级与局限

  • 证据类型:模拟ICU环境实验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为这些发现强调不同呼吸支持设备扩散病毒的风险可能存在差异,以及医务人员在照护可传播呼吸道病毒感染(如SARS-CoV-2)患者时采取适当感染防控措施和个人防护装备的重要性。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Rationale: Patients with severe coronavirus disease (COVID-19) require supplemental oxygen and ventilatory support. It is unclear whether some respiratory support devices may increase the dispersion of infectious bioaerosols and thereby place healthcare workers at increased risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).Objectives: To quantitatively compare viral dispersion from invasive and noninvasive respiratory support modalities.Methods: This study used a simulated ICU room with a breathing-patient simulator exhaling nebulized bacteriophages from the lower respiratory tract with various respiratory support modalities: invasive ventilation (through an endotracheal tube with an inflated cuff connected to a mechanical ventilator), helmet ventilation with a positive end-expiratory pressure (PEEP) valve, noninvasive bilevel positive-pressure ventilation, nonrebreather face masks, high-flow nasal oxygen (HFNO), and nasal prongs.Measurements and Main Results: Invasive ventilation and helmet ventilation with a PEEP valve were associated with the lowest bacteriophage concentrations in the air, and HFNO and nasal prongs were associated with the highest concentrations. At the intubating position, bacteriophage concentrations associated with HFNO (2.66 × 104 plaque-forming units [PFU]/L of air sampled), nasal prongs (1.60 × 104 PFU/L of air sampled), nonrebreather face masks (7.87 × 102 PFU/L of air sampled), and bilevel positive airway pressure (1.91 × 102 PFU/L of air sampled) were significantly higher than those associated with invasive ventilation (P < 0.05 for each). The difference between bacteriophage concentrations associated with helmet ventilation with a PEEP valve (4.29 × 10-1 PFU/L of air sampled) and bacteriophage concentrations associated with invasive ventilation was not statistically significant.Conclusions: These findings highlight the potential differential risk of dispersing virus among respiratory support devices and the importance of appropriate infection prevention and control practices and personal protective equipment for healthcare workers when caring for patients with transmissible respiratory viral infections such as SARS-CoV-2.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Avari H, Hiebert RJ, Ryzynski AA, et al. Quantitative Assessment of Viral Dispersion Associated with Respiratory Support Devices in a Simulated Critical Care Environment. Am J Respir Crit Care Med. 2021. PMID: 33534659. doi:10.1164/rccm.202008-3070OC

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。